# tVNS Research

> Health & Fitness

Canonical page: [https://chrome-stats.com/d/id6474557525](https://chrome-stats.com/d/id6474557525)

## Overview

- **ID:** `id6474557525`
- **Platform:** Apple
- **Type:** Apple app
- **Status:** Removed
- **Publisher:** tVNS Technologies
- **Category:** Health & Fitness
- **Version:** 2.0.2
- **Last updated:** 2024-03-19
- **First published:** 2024-02-07
- **Size:** 34 MB
- **Data as of:** 2026-09-03
- **Store listing:** [Apple App Store](https://apps.apple.com/us/app/tvns-research/id6474557525)
- **Website:** [https://t-vns.com/](https://t-vns.com/)
- **Privacy policy:** [https://t-vns.com/en/privacy-policy-research-app](https://t-vns.com/en/privacy-policy-research-app)

## Description

Using tVNS® Research, researchers can configure and program their tVNS nextGen devices.

tVNS® Research allows you to:

- Monitor the state of your tVNS® R device
- Update the RTC time for accurate logging of treatments
- Export the treatment logs saved in the device as a CSV file for analysis.
- Change all programmable stimulation parameters, such as frequency, intensity, duration, and many others.

tVNS® Research has a simple user interface that is separated into 3 tabs.
In the “Connect” tab, you can:
- Scan for tVNS® nextGen devices
- Connect and bond with tVNS® nextGen devices
- Monitor the state of your device and interact with the device

In the “Current Config” tab, you can:
- Examine the currently specified stimulation parameters
In the “Program” tab, you can:
- Easily program new treatment parameters onto any tVNS® R device within the specified ranges.

If you require support in your use of tVNS® Research, please contact support@t-vns.com for assistance.

Disclaimer: This app is intended for investigational use only.

## Similar extensions and apps

- [tVNS Connect](https://chrome-stats.com/d/id6741166913)
- [tVNS Patient](https://chrome-stats.com/d/id1576187054) — 3.00 / 5
- [Vagal Tones](https://chrome-stats.com/d/id1573243314) — 1.50 / 5
- [Neuvana NotreDame](https://chrome-stats.com/d/id6479176289)
- [REACH-tDCS Study](https://chrome-stats.com/d/id6502997289)
- [SONA VNS](https://chrome-stats.com/d/id6756424780) — 2.00 / 5
- [Patient Controller NR - US](https://chrome-stats.com/d/id1059237634) — 2.40 / 5
- [Patient Controller NR - CAN](https://chrome-stats.com/d/id1114594277)
- [Patient Controller NR - LATAM](https://chrome-stats.com/d/id1177791721) — 4.00 / 5
- [Patient Controller NR - RUS](https://chrome-stats.com/d/id1367238430) — 3.00 / 5
- [Patient Controller NR – EU](https://chrome-stats.com/d/id973338477)
- [Patient Controller NR - EMEA2](https://chrome-stats.com/d/id1127457714)

---

Source: [Chrome-Stats](https://chrome-stats.com/d/id6474557525)